⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11884121 | 0.69 | — | — | |
| SCHEMBL9260296 | 0.69 | — | — | |
| SCHEMBL9599 | 0.69 | — | — | |
| SCHEMBL1386969 | 0.69 | — | — | |
| SCHEMBL44720 | 0.69 | — | — | |
| SCHEMBL10760112 | 0.67 | — | — | |
| SCHEMBL5631495 | 0.65 | — | — | |
| SCHEMBL9417357 | 0.63 | — | — | |
| SCHEMBL220126 | 0.62 | — | — | |
| SCHEMBL15667522 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118048159-A | Reversible emulsifier and preparation method thereof | 中国石油天然气股份有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-20210015824-A1 | NOVEL PHARMACEUTICAL USE OF THIOPHENE [3,2-D] PYRIMIDINE-4-KETONE COMPOUND | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2021-01-21 | — | — | US | claimed |
| EP-3763716-A1 | NOVEL PHARMACEUTICAL USE OF THIOPHENE [3, 2-D] PYRIMIDINE-4-KETONE COMPOUND | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2021-01-13 | — | — | EP | claimed |
| EP-2786998-B1 | THIENYL [3, 2-D]PYRIMIDIN-4-ONE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2018-07-25 | — | — | EP | claimed |
| EP-3169662-B1 | SUBSTITUTED VINYL- AND ALKINYL-CYANOCYCLOALKANOLS AND VINYL- AND ALKINYL-CYANOHETEROCYCLOALKANOLS AS AGENTS TO COMBAT ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2018-07-11 | — | — | EP | claimed |
| US-10004702-B2 | Linear guanidine derivatives, methods of preparation and uses thereof | LEAD DISCOVERY SIENA S.R.L. (IT) | 2018-06-26 | — | — | US | claimed |
| US-20170304235-A1 | LINEAR GUANIDINE DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF | LEAD DISCOVERY SIENA S.R.L. (IT) | 2017-10-26 | — | — | US | claimed |
| EP-3203994-A1 | LINEAR GUANIDINE DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF | Lead Discovery Siena S.r.l. (IT) | 2017-08-16 | — | — | EP | claimed |
| WO-2016055644-A1 | LINEAR GUANIDINE DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF | LEAD DISCOVERY SIENA S.R.L. (IT) | 2016-04-14 | — | — | WO | claimed |
| US-9045491-B2 | Thienyl [3,2-D] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2015-06-02 | — | — | US | claimed |
| WO-2000043371-A2 | FUSED RING HETEROARYL AND HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 2000-07-27 | — | — | WO | claimed |
| EP-1001972-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| EP-1001973-A1 | COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0994896-A1 | SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-04-26 | — | — | EP | claimed |
| WO-1999006433-A1 | COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1999006437-A1 | SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1999006431-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1997027179-A2 | ANTIRETROVIRAL BASES | NOVARTIS AG (CH) | 1997-07-31 | — | — | WO | claimed |
| US-4737514-A | Method for treating depression with thioxanthen-9-one derivatives | BURROUGHS WELLCOME CO. (US) | 1988-04-12 | — | — | US | claimed |
| EP-0150891-A1 | Tricyclic compounds, processes for their preparation, compositions containing such compounds and their use in medicine | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-08-07 | — | — | EP | claimed |